Newsletter #9
Temperature Effects on Kd Measurements
As a general rule of thumb, the Kd becomes tighter and kinetic values will decrease as temperature decreases. We are aware of only a few cases where this rule is violated. For the most accurate data, binding measurements should be made under conditions as close to their intended application as possible. It is our opinion that, in pharmaceutical development, affinity and kinetic measurements should be made at 37°C since this is the temperature at which the final therapeutic will be delivered.
In keeping pace with the latest trends in physiologically relevant data measurements, we’re pleased to announce a temperature controlled chamber designed to accommodate any KinExA instrument, the TC1000.
With the TC1000 you can easily incubate samples and run experiments at any temperature between 4°C and 40°C. Temperature is automatically recorded for each sample run and interior cameras allow viewing inside the chamber without perturbing the inside environment. The wide range of temperatures allows estimation of the thermodynamic parameters of binding (change in enthalpy ΔH, change in entropy ΔS, and change in heat capacity ΔCp).

Additional features include:
- An integrated Windows 10 computer and monitor installed with KinExA Pro Software.
- Custom-made lab bench that is acid and chemical resistant and doubles as a convenient workstation.
- Level Sensors that monitor the buffer and waste levels.
- Replaceable air filters protect the evaporator and condenser coils from dirt and dust, maintaining high efficiency and reducing service needs.
- A tough steel interior and careful attention to design details ensure your unit will last and maintain a safe environment for the instrument and samples.
- Temperature uniformity allows for exact temperature control, providing more confidence in analysis results.
- Includes a one year warranty.
Sapidyne is accepting pre-orders for a 10% discount until January 31, 2021. The units will be available first quarter of 2021.
Contract KinExA Research
The unprecedented effects of COVID-19 are leaving many researchers tasked with catching up on a heavy workload and Sapidyne is here to help. Our contract research team is available to perform lead characterization (including cell based work) or third party verification for projects moving forward to an IND submission, FDA approval, or clinical trial. Services can be requested via our website, scientist.com, or scienceexchange.com.
Literature Spotlight: Capture Surface & SPR
In a recent study, scientists at Regeneron describe how SPR capture surfaces can profoundly impact the binding kinetics that are measured for molecular interactions. In the study, [6] different human monoclonal antibodies were measured using [8] different molecules on the capture surface. Binding constants measured using SPR were shown to be strongly influenced by the choice of capture molecule and consistently weaker than those measured in solution using KinExA. Depending on the immobilization molecule, SPR based Kd values were from 3 to 2826 times weaker than those measured using KinExA.
Kamat, Vishal, et al. “The impact of different human IgG capture molecules on the kinetics analysis of antibody-antigen interaction.” Analytical Biochemistry, 10 Jan. 2020. DOI: 10.1016/j.ab.2020.113580




